X
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://pharmaphorum.com/news/ucb-takes-on-jazz-in-severe-epilepsy-with-new-fintepla-approval/
https://www.globenewswire.com/news-release/2022/03/04/2397124/0/en/Zogenix-To-Present-New-Long-term-Data-on-FINTEPLA-fenfluramine-in-Lennox-Gastaut-Syndrome-LGS-at-AAN-2022.html
https://www.globenewswire.com/news-release/2022/02/28/2393133/0/en/Zogenix-Provides-Corporate-Update-and-Reports-Fourth-Quarter-and-Full-Year-2021-Financial-Results.html
https://endpts.com/zogenix-pulls-controversial-opioid-zohydro-er-from-the-market-ahead-of-ucb-acquisition/
https://www.biopharmadive.com/news/ucb-zogenix-acquire-deal-epilepsy-drug/617337/
https://www.globenewswire.com/news-release/2021/12/21/2356048/0/en/Zogenix-Submits-New-Drug-Application-for-FINTEPLA-Fenfluramine-in-Japan-for-the-Treatment-of-Epileptic-Seizures-Associated-with-Dravet-Syndrome.html
https://www.globenewswire.com/news-release/2021/12/20/2355192/0/en/Zogenix-Submits-Type-II-Variation-Application-to-the-European-Medicines-Agency-EMA-to-Expand-the-Use-of-FINTEPLA-Fenfluramine-for-the-Treatment-of-Seizures-Associated-with-Lennox-G.html
https://www.globenewswire.com/news-release/2021/12/16/2354076/0/en/Zogenix-Reports-Granting-of-Inducement-Awards.html
https://www.globenewswire.com/news-release/2021/11/01/2324354/0/en/Zogenix-to-Host-Key-Opinion-Leader-Webinar-on-Thymidine-Kinase-2-Deficiency-and-MT-1621.html
https://www.globenewswire.com/news-release/2021/09/28/2304386/0/en/Zogenix-Submits-Supplemental-New-Drug-Application-for-FINTEPLA-Fenfluramine-for-the-Treatment-of-Seizures-Associated-with-Lennox-Gastaut-Syndrome.html
Market Place
Share 
